A Study of PM1015 in Patients With Advanced Solid Tumors
NCT05950815
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
CD73 Antigen
Sponsor
Biotheus Inc.